Menopause and female sexual dysfunctions

Minerva Obstet Gynecol. 2022 Jun;74(3):234-248. doi: 10.23736/S2724-606X.22.05001-1. Epub 2022 Feb 2.

Abstract

Biological and psycho-relational factors contribute equally to the development of sexual symptoms and associated distress, a key element to diagnose female sexual dysfunctions (FSDs) in menopausal women. Consultation at midlife represents an optimal time to discuss sexual life, and healthcare providers have to be proactive in rising the conversation, as patients may not report their sexual concerns spontaneously. An accurate sexual history is essential to characterize the primary symptom, determine the impact on patient's quality of life and identify risk and precipitating factors. Among FSDs, hypoactive sexual desire disorder is very frequent at midlife together with genitourinary syndrome of menopause, a chronic condition negatively affecting the full sexual response. A multidimensional approach targeted to the patient's characteristics, goals and expectations is mandatory and should start from educative counselling and correction of modifiable risk factors. When specific treatments are required, they should include non-pharmacological and pharmacological options, often prescribed in combination to address concomitantly the biological and psychosocial components of FSDs.

MeSH terms

  • Female
  • Humans
  • Menopause
  • Quality of Life*
  • Sexual Behavior / psychology
  • Sexual Dysfunctions, Psychological* / diagnosis